GILL DAVID N (CIK 1106519) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-19). Recent activity: Buy EOLS (45,559 shares), Sell YMAB (5,825 shares), Sell YMAB (25,080 shares), Buy YMAB (25,080 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-19 | Evolus, Inc. (EOLS) | Director | Buy | 45,559 | $0 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 5,825 | $50,095 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 25,080 | $0 |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Buy | 25,080 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-02-19